Denali Therapeutics
DNLI
DNLI
58 hedge funds and large institutions have $1.2B invested in Denali Therapeutics in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.12% more ownership
Funds ownership: 64.56% → 64.69% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
58
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$20.8M | |
| 2 | +$8.34M | |
| 3 | +$7.32M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$5.6M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$5.34M |
Top Sellers
| 1 | -$7.57M | |
| 2 | -$1.85M | |
| 3 | -$1.48M | |
| 4 |
Millennium Management
New York
|
-$1.48M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$1.02M |